StockData
Verrica Pharmaceuticals Inc. logo

Verrica Pharmaceuticals Inc. (VRCA) stock

VRCANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$3.14−0.06 (-1.88%)

Close on Nov 17, 2026Market cap $53.94MP/E –Yield –

Verrica Pharmaceuticals gross margin

Gross margin is gross profit as a percentage of revenue.

Verrica Pharmaceuticals's gross margin for the twelve months ending Mar 31, 2025 was 63.8%. For fiscal 2024 it was 65.6%, against 90.2% the year before.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2024Dec 31, 202465.6%−24.6
FY2023Dec 31, 202390.2%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q1 FY2025Mar 31, 202579.6%−10.3
Q4 FY2024Dec 31, 2024-132.6%−222.3
Q2 FY2024Jun 30, 202486.5%–
Q1 FY2024Mar 31, 202481.7%–
Q4 FY2023Dec 31, 202389.9%–
Q3 FY2023Sep 30, 202389.7%–

More Verrica Pharmaceuticals figures

See a number that looks wrong?